|
1
|
Bolukbas C, Bolukbas FF, Horoz M, Aslan M,
Celik H and Erel O: Increased oxidative stress associated with the
severity of the liver disease in various forms of hepatitis B virus
infection. BMC Infect Dis. 5:952005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Muriel P: Role of free radicals in liver
diseases. Hepatol Int. 3:526–536. 2009. View Article : Google Scholar
|
|
3
|
Demirdag K, Yilmaz S, Ozdarendeli A, Ozden
M, Kalkan A and Kilic SS: Levels of plasma malondialdehyde and
erythrocyte antioxidant enzyme activities in patients with chronic
hepatitis B. Hepatogastroenterology. 50:766–770. 2003.PubMed/NCBI
|
|
4
|
Chrobot AM, Szaflarska-Szczepanik A and
Drewa G: Antioxidant defense in children with chronic viral
hepatitis B and C. Med Sci Monit. 6:713–718. 2000.PubMed/NCBI
|
|
5
|
Matiushin BN, Loginov AS, Iakimchuk GN and
Tkachev VD: Activity of blood antioxidant enzymes in chronic liver
damage. Vopr Med Khim. 41:54–56. 1995.(In Russian).
|
|
6
|
Ogetman Z, Dirlik M, Caglikulekci M, et
al: The effect of aminoguanidine on blood and tissue lipid
peroxidation in jaundiced rats with endotoxemia induced with LPS. J
Invest Surg. 19:19–30. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Han DW: Intestinal endotoxemia as a
pathogenetic mechanism in liver failure. World J Gastroenterol.
8:961–965. 2002.PubMed/NCBI
|
|
8
|
Lin RS, Lee FY, Lee SD, et al: Endotoxemia
in patients with chronic liver diseases: relationship to severity
of liver diseases, presence of esophageal varices, and hyperdynamic
circulation. J Hepatol. 22:165–172. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li L, Wu Z, Ma W, Yu Y and Chen Y: Changes
in intestinal microflora in patients with chronic severe hepatitis.
Chin Med J (Engl). 114:869–872. 2001.PubMed/NCBI
|
|
10
|
Ballongue J, Schumann C and Quignon P:
Effects of lactulose and lactitol on colonic microflora and
enzymatic activity. Scand J Gastroenterol Suppl. 222:41–44.
1997.PubMed/NCBI
|
|
11
|
Ito M, Sawada H, Ohishi K, et al:
Suppressive effects of bifidobacteria on lipid peroxidation in the
colonic mucosa of iron-overloaded mice. J Dairy Sci. 84:1583–1589.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
The prevention and treatment programs of
Viral hepatitis. Chin J Infect Dis. 19:56–62. 2001.
|
|
13
|
Wang P, Xu TY, Guan YF, Su DF, Fan GR and
Miao CY: Perivascular adipose tissue-derived visfatin is a vascular
smooth muscle cell growth factor: role of nicotinamide
mononucleotide. Cardiovasc Res. 81:370–380. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xing HC, Li LJ, Xu KJ, et al: Protective
role of supplement with foreign Bifidobacterium and Lactobacillus
in experimental hepatic ischemia-reperfusion injury. J
Gastroenterol Hepatol. 21:647–656. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang P, Xu TY, Guan YF, et al:
Nicotinamide phosphoribosyltransferase protects against ischemic
stroke through SIRT1-dependent adenosine monophosphate-activated
kinase pathway. Ann Neurol. 69:360–374. 2011. View Article : Google Scholar
|
|
16
|
Chen C, Li L, Wu Z, Chen H and Fu S:
Effects of lactitol on intestinal microflora and plasma endotoxin
in patients with chronic viral hepatitis. J Infect. 54:98–102.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yesilova Z, Yaman H, Oktenli C, et al:
Systemic markers of lipid peroxidation and antioxidants in patients
with nonalcoholic fatty liver disease. Am J Gastroenterol.
100:850–855. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Konishi M, Iwasa M, Araki J, et al:
Increased lipid peroxidation in patients with non-alcoholic fatty
liver disease and chronic hepatitis C as measured by the plasma
level of 8-isoprostane. J Gastroenterol Hepatol. 21:1821–1825.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Swietek K and Juszczyk J: Reduced
glutathione concentration in erythrocytes of patients with acute
and chronic viral hepatitis. J Viral Hepat. 4:139–141. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Irshad M, Chaudhuri PS and Joshi YK:
Superoxide dismutase and total anti-oxidant levels in various forms
of liver diseases. Hepatol Res. 23:178–184. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Finney M, Smullen J, Foster HA, Brokx S
and Storey DM: Effects of low doses of lactitol on faecal
microflora, pH, short chain fatty acids and gastrointestinal
symptomology. Eur J Nutr. 46:307–314. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kitler ME, Luginbuhl M, Lang O, Wuhl F,
Wyss A and Lebek G: Lactitol and lactulose, an in vivo and in vitro
comparison of their effects on the human intestinal flora. Drug
Investigation. 4:73–82. 1992. View Article : Google Scholar
|
|
23
|
Kummel KF and Brokx S: Lactitol as a
functional prebiotic. Cereal Foods World. 46:424–429. 2001.
|
|
24
|
Lang CH, Silvis C, Deshpande N, Nystrom G
and Frost RA: Endotoxin stimulates in vivo expression of
inflammatory cytokines tumor necrosis factor alpha,
interleukin-1beta, -6, and high-mobility-group protein-1 in
skeletal muscle. Shock. 19:538–546. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Caglikulekci M, Dirlik M, Pata C, et al:
Effect of N-acetylcysteine on blood and tissue lipid peroxidation
in lipopolysaccharide-induced obstructive jaundice. J Invest Surg.
19:175–184. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shen KP, Lo YC, Yang RC, Liu HW, Chen IJ
and Wu BN: Antioxidant eugenosedin-A protects against
lipopolysaccharide-induced hypotension, hyperglycaemia and cytokine
immunoreactivity in rats and mice. J Pharm Pharmacol. 57:117–125.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang G, Feng Y, Wang Y, Huang N, Wu Q and
Wang B: Bifidobacterium cell wall proteins induced beta-defensin 2
mRNA expression in human intestinal epithelial cells. Sichuan Da
Xue Xue Bao Yi Xue Ban. 34:622–624. 2003.(In Chinese).
|
|
28
|
Sageman WS: Reliability and precision of a
new thoracic electrical bioimpedance monitor in a lower body
negative pressure model. Crit Care Med. 27:1986–1990. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin MY and Chang FJ: Antioxidative effect
of intestinal bacteria Bifidobacterium longum ATCC 15708 and
Lactobacillus acidophilus ATCC 4356. Dig Dis Sci. 45:1617–1622.
2000. View Article : Google Scholar : PubMed/NCBI
|
